Atacama Therapeutics, Inc. — Form D/A
Atacama Therapeutics, Inc. of WELLESLEY, MA, a company, filed a Form D amendment with the SEC on 2024-05-07. The offering totals $4.7M, of which $830K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-05-07
- Form: D/A
- Accession: 0002022176-24-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.7M
- Amount sold: $830K
- Remaining: $3.9M
- Minimum investment: $3K
- Investors: 16
- Date of first sale: 2024-04-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-512480
Issuer
- Name: Atacama Therapeutics, Inc.
- CIK: 0002022176
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 65 WILLIAM STREET, WELLESLEY, MA, 02481
- Phone: 617-225-7700
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Joseph Baron | Director | Wellesley, MA |
| Jonathan Reis | Director | Wellesley, MA |
| Joseph Baron | Executive Officer | Wellesley, MA |
| David Dove | Director | Wellesley, MA |
Other filings by this issuer (1)
More